Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada

Jafari S, Buxton JA, Joe R. Rising fentanyl-related overdose deaths in British Columbia. Can J Addict. 2015;6(1):4–6.

Klar S, Brodkin E, Gibson E, Padhi S, Predy C, Green C, Lee V. Notes from the field. Furanyl-fentanyl overdose events caused by smoking contaminated crack cocaine — British Columbia, Canada, July 15–18, 2016. Morb Mortal Wkly Rep. 2016;65(37):1015–6.

Paix A, Coleman A, Lees J, Grigson J, Brooksbank M, Thorne D, Ashby M. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain. 1995;63(2):263–9.

Suzuki J, El-Haddad S. A review: fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017;171:107–16.

Young MM, Pirie T, Buxton JA, Hosein FS. The rise of overdose deaths involving fentanyl and the value of early warning. Can J Addict. 2015;6(3):13–7.

Armenian P, Vo KT, Barr-Walker J, Lynch KL. Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology. 2017;134:121–32.

O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700 — 10 states, July–December 2016. In: MMWR Morb mortal Wkly rep. Vol. 66: Centers for Disease Control and Prevention; 2017. p. 1197–202.

Cocaine laced with fentanyl a growing concern: 9 overdoses in 20 minutes in Delta. http://www.cbc.ca/news/canada/british-columbia/delta-police-nine-overdose-warning-1.3744776 . Accessed 7 Mar 2018.

BC Coroners Service. Fentanyl-detected illicit drug overdose deaths, 2012-2017; 2017. p. 19–22.

Amlani A, McKee G, Khamis N, Raghukumar G, Tsang E, Buxton JA. Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada. Harm Reduct J. 2015;12(1):1–7.

Kenney SR, Anderson BJ, Conti MT, Bailey GL, Stein MD. Expected and actual fentanyl exposure among persons seeking opioid withdrawal management. J Subst Abus Treat. 2018;86:65–9.

Wood E, Tyndall MW, Zhang R, Stoltz J-A, Lai C, Montaner JS, Kerr T. Attendance at supervised injecting facilities and use of detoxification services. N Engl J Med. 2006;354(23):2512–4.

Boyd N. Lessons from INSITE, Vancouver's supervised injection facility: 2003–2012. Drugs Educ Prev Policy. 2013;20(3):234–40.

Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV/AIDS Rep. 2017;14(5):161–83.

Schroers A. Drug checking: monitoring the contents of new synthetic drugs. J Drug Issues. 2002;32(2):635–46.

Hondebrink L, Nugteren-van Lonkhuyzen JJ, Van Der Gouwe D, Brunt TM. Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre. Drug Alcohol Depend. 2015;147:109–15.

Harper L, Powell J, Pijl EM. An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services. Harm Reduct J. 2017;14(1):52.

Brunt T: Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges. 2017.

Toumbourou JW, Stockwell T, Neighbors C, Marlatt G, Sturge J, Rehm J. Interventions to reduce harm associated with adolescent substance use. Lancet. 2007;369(9570):1391–401.

Winstock AR, Wolff K, Ramsey J. Ecstasy pill testing: harm minimization gone too far? Addiction. 2001;96(8):1139–48.

Hungerbuehler I, Buecheli A, Schaub M. Drug checking: a prevention measure for a heterogeneous group with high consumption frequency and polydrug use-evaluation of zurich's drug checking services. Harm Reduct J. 2011;8:16.

Brunt TM, Nagy C, Bücheli A, Martins D, Ugarte M, Beduwe C, Ventura Vilamala M. Drug testing in Europe: monitoring results of the trans European drug information (TEDI) project. Drug Test Anal. 2017;9(2):188–98.

Sage C: Harm reduction and drug checking; a wrap-around service for festivals. Case Study: Shambhala Music Festival. 2016.

Vancouver Coastal Health. Insite user statistics. Vancouver. http://www.vch.ca/public-health/harm-reduction/supervised-consumption-sites/insite-user-statistics . Accessed 7 Mar 2018.

Potier C, Laprévote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48–68.

Sherman S, Green T. Fentanyl Overdose Reduction Checking Analysis Study (FORECAST). Baltimore: Bloomberg American Health Initiative; 2018.

Drug Analysis Service: Summary report of samples analysed. https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/drug-analysis-service/2016-drug-analysis-service-summary-report-samples-analysed.html#a3 . Accessed 7 Mar 2018.

Hayashi K, Milloy MJ, Lysyshyn M, DeBeck K, Nosova E, Wood E, Kerr T. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: a cross-sectional urine toxicology screening study. Drug Alcohol Depend. 2018;183:1–6.

Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–74.

Lefrançois E, Augsburger M, Esseiva P. Drug residues in used syringes in Switzerland: a comparative study. Drug Test Anal. 2017;10:874–79.

Jones JD, Campbell A, Metz VE, Comer SD. No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone. Addict Behav. 2017;71:104–6.

Latimer J, Ling S, Flaherty I, Jauncey M, Salmon AM. Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre. Int J Drug Policy. 2016;37:111–4.

Kennedy MC, Scheim A, Rachlis B, Mitra S, Bardwell G, Rourke S, Kerr T. Willingness to use drug checking within future supervised injection services among people who inject drugs in a mid-sized Canadian city. Drug Alcohol Depend. 2018;185:248–52.

Health Canada is advising Canadians of the potential limitations when using test strips to detect fentanyl. http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/65406a-eng.php . Accessed 7 Mar 2018.

Karamouzian M, Kerr T. A public health approach to opioid addiction in North America. Lancet. 2018;391(10117):201–2.

Deeks JJ, Higgins JP. Statistical algorithms in review manager 5. Statistical Methods Group of The Cochrane Collaboration; 2010. p. 1–11.